Medtronic has received FDA clearance for a mobile app that allows patients to remotely forward data from their pacemakers with their physicians. The app is paired with a device, the MyCareLink Smart ...
The U.S. Food and Drug Administration has given Medtronic (NYSE:MDT) the go-ahead on a clinical trial to test its next generation of MRI pacemaker technology, the Minnesota company announced Monday.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results